AGR2 anticorps (N-Term)
Aperçu rapide pour AGR2 anticorps (N-Term) (ABIN6252575)
Antigène
Voir toutes AGR2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- N-Term
-
Purification
- Protein G affinity chromatography
-
Immunogène
- A recombinant protein fragment from the N-terminal region of human AGR2 was used as the immunogen for this antibody.
-
Isotype
- IgG1 kappa
-
-
-
-
Indications d'application
-
Western blot: 4-8 μg/mL
IHC (FFPE): 3-5 μg/mL
Provided assay concentrations are suggestions only, AGR2 antibody titration may be required for optimal results. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot and Store at -20C. Avoid freez-thaw cycles.
-
-
- AGR2 (Anterior Gradient Homolog 2 (Xenopus Laevis) (AGR2))
-
Autre désignation
- AGR2
-
Sujet
- AGR2 (Anterior gradient protein 2 homolog) is thought to promote breast tumorigenesis and is overexpressed in breast cancer cells. High levels of AGR2 indicate a poor prognosis. This suggests it may serve as a useful prognostic indicator and marker of breast cancer metastasis.
-
ID gène
- 10551
-
UniProt
- O95994
Antigène
-